Search

Search Constraints

You searched for: Author/Creator Ribrag, V

Search Results

1. 1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. (23rd October 2018)

2. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018)

3. 1885PPrecision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial. (23rd October 2018)

4. 296PApplicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). (23rd October 2018)

5. CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY. (17th June 2021)

6. S217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T-CELL LYMPHOMA AND 51 CUTANEOUS T-CELL LYMPHOMA SUBJECTS WITH RELAPSED REFRACTORY DISEASE. (23rd June 2022)